Canada Pension Plan Investment Board’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-700	Closed	-$34K	–	1396
2020 Q2	$34K	Buy	+700	New	+$34.9K	﹤0.01%	1333
2019 Q3	–	Sell	-7,648	Closed	-$426K	–	1305
2019 Q2	$426K	Sell	7,648 -3,789	-33%	-$198K	﹤0.01%	1096
2019 Q1	$577K	Sell	11,437 -9,863	-46%	-$439K	﹤0.01%	1157
2018 Q4	$858K	Sell	21,300 -12,800	-38%	-$660K	﹤0.01%	1098
2018 Q3	$2.36M	Buy	34,100 +32,800	+2,523%	+$2.49M	﹤0.01%	991
2018 Q2	$98K	Buy	+1,300	New	+$81.8K	﹤0.01%	1172

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Pension Plan Investment Board's EGRX Position: Q3 2020 in Review

Canada Pension Plan Investment Board sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2020, closing a stake of 700 shares — an estimated $34K sold.

Canada Pension Plan Investment Board first reported a position in EGRX in Q2 2018 and held it in 6 quarters. The position peaked at $2.36M in Q3 2018. 171 funds tracked by Wall St. Rank hold EGRX as of Q3 2020.

Canada Pension Plan Investment Board reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Canada Pension Plan Investment Board sold 700 Eagle Pharmaceuticals, Inc. shares in Q3 2020, an estimated $34K.
Canada Pension Plan Investment Board first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2018 and held it in 6 quarters.
Canada Pension Plan Investment Board's Eagle Pharmaceuticals, Inc. position peaked at $2.36M in Q3 2018.
171 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2020, filed 12 Nov 2020.